No connection

Search Results

AGNCN

BEARISH
$25.6 Live
AGNC Investment Corp. · NASDAQ
$23.63 52W Range $26.59

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Mar 14, 2026
Market cap
$8.79B
P/E
N/A
ROE
15.1%
Profit margin
92.9%
Debt/Equity
6.89
Dividend yield
9.32%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
AGNCN exhibits a weak Piotroski F-Score of 3/9, indicating deteriorating financial health, and lacks an Altman Z-Score, raising unquantified distress risk. Despite strong revenue and earnings growth (546% and 772% YoY), the company's extreme debt/equity ratio of 6.89, near-zero liquidity (current ratio 0.18), and negative operating cash flow (implied by missing data) signal severe financial fragility. The stock trades at a rich Price/Book of 2.72 and offers a high 9.32% dividend yield, but the payout ratio is unverifiable and likely unsustainable given the weak profitability metrics and negative cash flow. The technical trend is bearish, and analyst coverage is absent, amplifying uncertainty.

Key Strengths

Exceptional year-over-year revenue and earnings growth (546% and 772%)
High gross margin (100.00%) and strong operating margin (95.88%)
Significant 5-year price appreciation (+55.3%)
High dividend yield of 9.32% attractive to income investors
Strong relative performance in peer group (1Y return +7.3%)

Key Risks

Piotroski F-Score of 3/9 indicates weak financial health and declining fundamentals
Debt/Equity ratio of 6.89 is extremely high, signaling leverage risk
Current and quick ratios of 0.18 and 0.17 suggest severe liquidity constraints
Missing Free Cash Flow and Operating Cash Flow data raises red flags on cash generation
No analyst coverage or target price undermines market confidence and valuation clarity
Lack of Altman Z-Score implies unassessed bankruptcy risk

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
45
Moderate
Value
40
Future
75
Past
55
Health
25
Dividend
30
AI Verdict
Weak
Key drivers: Low Piotroski F-Score (3/9), Extreme leverage (Debt/Equity 6.89), Near-zero liquidity, Missing cash flow data, High yield with unverifiable payout ratio
Confidence
85%
Value
40/100

Stock trades at a premium valuation due to high growth expectations, but lacks fundamental support from cash flow or sustainable profitability metrics.

Positives
  • High revenue and earnings growth rates
  • Strong gross and operating margins
Watchpoints
  • Price/Book of 2.72 is elevated
  • No Graham Number or intrinsic value estimate available
  • High P/E and PEG not available, but implied premium valuation
Future
75/100

Exceptional growth metrics suggest strong momentum, but the sustainability of such growth is questionable given deteriorating balance sheet health.

Positives
  • 546.10% YoY revenue growth
  • 772.40% YoY earnings growth
  • 682.00% Q/Q earnings growth
Watchpoints
  • Growth may be unsustainable given financial health
  • No forward guidance or analyst estimates
  • High leverage could constrain future expansion
Past
55/100

Strong historical price performance, but underlying financials show signs of deterioration, undermining long-term reliability.

Positives
  • 5-year price return of +55.3%
  • 1-year return of +7.3%
  • Consistent 52-week high above current price
Watchpoints
  • Recent 1-month price decline (-0.6%)
  • Lack of long-term financial trend data
  • No historical ROE or ROA trends available
Health
25/100

Despite strong margin performance, the company's financial health is severely compromised by excessive leverage and liquidity risk.

Positives
  • High operating margin (95.88%)
  • High gross margin (100.00%)
Watchpoints
  • Piotroski F-Score of 3/9 (weak)
  • Debt/Equity of 6.89 (very high)
  • Current ratio of 0.18 (extremely low)
  • No Altman Z-Score available (unassessed distress risk)
  • Missing cash flow data
Dividend
30/100

The high yield is a red flag rather than a strength, as it may be funded by debt or capital depletion rather than earnings.

Positives
  • High dividend yield of 9.32%
  • Attractive for income-focused investors
Watchpoints
  • Payout ratio not available (likely unsustainable)
  • No evidence of cash flow backing the dividend
  • High leverage and weak cash flow suggest dividend may be at risk

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$25.6

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for AGNCN and closest competitors.

Updated 2026-03-13
AGN
AGNC Investment Corp.
Primary
5Y
+55.3%
3Y
+40.2%
1Y
+7.3%
6M
+3.6%
1M
-0.6%
1W
+0.0%
AGN
AGNC Investment Corp.
Peer
5Y
+47.6%
3Y
+44.5%
1Y
+6.7%
6M
+3.8%
1M
-0.8%
1W
-0.4%
AHR
American Healthcare REIT, Inc.
Peer
5Y
+278.7%
3Y
+278.7%
1Y
+65.4%
6M
+25.2%
1M
-4.0%
1W
-3.7%
LIN
Lineage, Inc.
Peer
5Y
-53.9%
3Y
-53.9%
1Y
-30.4%
6M
-10.3%
1M
-10.9%
1W
+4.2%
ADC
Agree Realty Corporation
Peer
5Y
+38.9%
3Y
+12.4%
1Y
+5.9%
6M
+0.8%
1M
+0.6%
1W
-0.9%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
2.72
P/S Ratio
4.89
EV/Revenue
54.8
EV/EBITDA
N/A
Market Cap
$8.79B

Profitability

Profit margins and return metrics

Profit Margin 92.93%
Operating Margin 95.88%
Gross Margin 100.0%
ROE 15.08%
ROA 1.65%

Growth

Revenue and earnings growth rates

Revenue Growth +546.1%
Earnings Growth +772.4%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth +682.0%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
6.89
High debt
Current Ratio
0.18
Weak
Quick Ratio
0.17
Poor
Cash/Share
$15.54

Real Estate Sector Comparison

Comparing AGNCN against 91 companies in the Real Estate sector (4 bullish, 12 neutral, 75 bearish)
Return on Equity (ROE)
15.08%
This Stock
vs
-55.73%
Sector Avg
-127.1% (Below Avg)
Profit Margin
92.93%
This Stock
vs
10.59%
Sector Avg
+777.3% (Superior)
Debt to Equity
6.89
This Stock
vs
2.52
Sector Avg
+173.7% (Higher)
Revenue Growth
546.1%
This Stock
vs
29720.08%
Sector Avg
-98.2% (Slower)
Current Ratio
0.18
This Stock
vs
6.52
Sector Avg
-97.2% (Weaker)

Similar Companies

Peer comparison within the same industry

Past News Coverage

Recent headlines mentioning AGNCN from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile